Clinics in Orthopedic Surgery is a premier open-access journal dedicated to advancing the field of orthopedics, published by the Korean Orthopaedic Association. With its ISSN 2005-291X and E-ISSN 2005-4408, this journal provides a dynamic platform for disseminating high-quality research and clinical insights relevant to orthopedic surgery. Since its inception in 2009, it has established a commendable reputation within the academic community, achieving a Q1 ranking in both Orthopedics and Sports Medicine, and Surgery for 2023, as well as notable Scopus rankings. This journal not only facilitates global access to cutting-edge research but also aims to foster collaboration among researchers, professionals, and students alike. Its comprehensive scope and open-access model enhance the visibility and impact of published works, ensuring that critical advancements in orthopedic knowledge reach a wide audience. As it continues to cover diverse topics within the field through 2024 and beyond, Clinics in Orthopedic Surgery remains an essential resource for those invested in orthopedic practice and surgery.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, published by SAGE Publications Ltd, serves as a vital platform in the fields of biochemistry and medicine, showcasing significant research contributions since its inception in 1972. With an Open Access policy implemented in 2012, this journal promotes unrestricted dissemination of knowledge, catering to a global audience and ensuring that critical findings are accessible to researchers, healthcare professionals, and students alike. With an impressive scope spanning diverse biomedical disciplines, the journal ranks in the Q3 quartile for both biochemistry and medicine, affirming its relevance and impact within these evolving fields. Hailing from the United Kingdom, the journal is dedicated to fostering a rich academic dialogue that bridges laboratory discoveries and clinical applications, making it an essential resource for those engaged in international medical research. Its ongoing commitment to excellence is reflected in its convergence until 2024, inviting high-quality submissions that contribute to advancements in medical science.

Gastric Cancer is a leading journal in the field of oncology, published by SPRINGER in Japan. With an ISSN of 1436-3291 and an E-ISSN of 1436-3305, this esteemed journal aims to disseminate high-quality research focused on all aspects of gastric cancer, including its pathophysiology, diagnosis, treatment, and prevention. As an indicator of its academic excellence, Gastric Cancer is ranked in the top quartile (Q1) for Cancer Research, Gastroenterology, Medicine (miscellaneous), and Oncology categories as of 2023. The journal holds impressive Scopus rankings, being positioned #9 in Gastroenterology and #34 in Oncology, demonstrating its critical role in shaping advancements within these disciplines. Although not an open-access publication, it provides various access options for institutions and individuals looking to elevate their understanding of gastric cancer. With a converged publication history from 2000 to 2024, it serves as a vital resource for researchers, professionals, and students dedicated to eradicating this formidable disease.

CNS DRUGS is a leading journal dedicated to the field of neuroscience, specifically focused on the advancement of pharmacological therapies for central nervous system disorders. Published by ADIS INT LTD, this esteemed journal has maintained a strong impact within its domain, achieving Q1 rankings in 2023 across multiple categories, including Neurology (clinical), Pharmacology (medical), and Psychiatry and Mental Health. With an impressive Scopus ranking as the 11th of 272 in medical pharmacology and high percentiles in psychiatry and neurology, it fosters high-quality research publication and dissemination. Spanning over two decades from 1994 to 2024, CNS DRUGS serves as a vital resource for researchers, professionals, and students alike, providing comprehensive insights that drive innovation in clinical practices. Although primarily a subscription-based journal, the richness of its content makes it an essential addition to any institution's library. Striving to bridge the gap between scientific research and clinical application, CNS DRUGS is positioned at the forefront of neurological and psychiatric pharmacotherapy research.

Global Journal of Medical Pharmaceutical and Biomedical Update, published by SCIENTIFIC SCHOLAR LLC, is a premier platform dedicated to advancing knowledge in the fields of medicine, pharmaceuticals, and biomedical sciences. With an E-ISSN of 2765-8910, this journal aims to foster innovative research and insightful discussions by providing open access to high-quality peer-reviewed articles. It serves as an invaluable resource for researchers, professionals, and students alike, ensuring that the latest advancements, methodologies, and findings are accessible to a diverse audience. Located at 50, Woodgreen Dr, Pittsford, NY 14534, the journal prioritizes the dissemination of critical information that addresses the evolving challenges faced in healthcare and biomedical research, ultimately contributing to the betterment of global health outcomes.

Journal of Personalized Medicine is a pioneering open-access journal published by MDPI, renowned for its commitment to advancing research in the dynamic field of personalized healthcare. Since its inception in 2011, this journal has served as a critical platform for scholars, practitioners, and students interested in the integration of individualized therapies and diagnostic techniques that aim to tailor medical treatments to the unique characteristics of each patient. With an impressive Q2 ranking in the field of medicine, as recognized by Scopus, and currently holding a percentile rank of 65th, it stands out among its peers with a focus on innovative approaches that challenge traditional paradigms. Researchers can benefit from its open-access model, allowing for broader dissemination of findings that can significantly impact clinical practices and research directions globally. Set against the picturesque backdrop of Basel, Switzerland, the journal is positioned at the forefront of medical innovation, producing high-quality, peer-reviewed articles that span the latest advancements and applications in personalized medicine.

The American Journal of the Medical Sciences, published by Elsevier Science Inc, has been a cornerstone in the field of medicine since its inception in 1945. With ISSN 0002-9629 and E-ISSN 1538-2990, this esteemed journal provides a comprehensive forum for the dissemination of cutting-edge research and clinical advancements across various medical disciplines. It currently holds a distinguished Q2 ranking in the field of Medicine (miscellaneous) and ranks #118 out of 636 in General Medicine on Scopus, reflecting its significant impact with an 81st percentile rating. While it operates under a traditional publishing model, which ensures rigorous peer-review processes, its commitment to disseminating vital medical knowledge remains paramount. Based in the United States at STE 800, 230 Park Ave, New York, NY 10169, the journal aims to bridge the gap between research and practice, making it an invaluable resource for researchers, healthcare professionals, and students dedicated to advancing medical science and improving patient care.

The New England Journal of Medicine (NEJM), published by the Massachusetts Medical Society, stands as a beacon of excellence in the field of medicine. With an impressive impact factor and a prestigious rank of #2 out of 636 in General Medicine, NEJM is recognized in the Q1 category for its significant contributions to medical research and clinical practice since its inception in 1945. The journal is renowned for publishing groundbreaking studies, reviews, and commentaries that influence clinical guidelines and healthcare policies worldwide. While the journal is not open access, it provides pivotal resources that are essential for researchers, healthcare professionals, and students looking to stay abreast of the latest developments in medicine. With a commitment to advancing medical knowledge, NEJM plays a crucial role in bridging the gap between laboratory research and clinical application.

The International Journal of Rheumatology, published by HINDAWI LTD, serves as a vital resource for researchers and practitioners in the fields of rheumatology and immunology. Since its inception in 2009 as an Open Access journal, it has aimed to disseminate high-quality, peer-reviewed research to foster advancements in the understanding and treatment of rheumatic diseases. With an ISSN of 1687-9260 and E-ISSN of 1687-9279, the journal has become increasingly relevant, achieving a respectable Q3 ranking in both the Immunology and Rheumatology categories in 2023, and earning a Scopus rank of #27 out of 73 in Medicine Rheumatology. The journal's commitment to excellence is reflected in its wide-ranging scope, addressing current trends and innovations through empirical studies, reviews, and clinical insights. Its global readership, based in the United States and beyond, highlights the journal's importance in shaping the discourse within rheumatological research. As it converges through the years from 2010 to 2024, the International Journal of Rheumatology continues to be a cornerstone for sharing groundbreaking findings and fostering collaboration in the rheumatic disease community.

Journal of Clinical Medicine Research-Canada is a prestigious and dynamic platform dedicated to the dissemination of novel research in the field of medicine. Published by ELMER PRESS INC, the journal has gained a significant reputation since its inception, achieving an impressive Q2 ranking in the Medicine (miscellaneous) category and placing within the 85th percentile of general medicine rankings in Scopus. This indicates its notable contribution and relevance within the medical community. As an active participant in global healthcare discussions, the journal covers a wide spectrum of topics, ranging from clinical practices to innovative therapeutic interventions. With its commitment to delivering high-quality, peer-reviewed content, the Journal of Clinical Medicine Research-Canada serves as an invaluable resource for researchers, professionals, and students looking to stay at the forefront of medical advancements. Though currently not an Open Access journal, it remains a critical publication for those seeking to deepen their understanding and engage with cutting-edge research in the field. The journal is headquartered in Ontario, Canada, and encourages submissions that push the boundaries of clinical medicine, thereby fostering an environment of scholarly excellence.